Low pre-ART CD4 count is associated with increased risk of clinical progression or death even after reaching 500 CD4 cells/μL on ART

Low pre-ART CD4 count is associated with increased risk of clinical progression or death even after reaching 500 CD4 cells/μL on ART

Show other versions (1)

<h4>Introduction</h4> Clinical disadvantages of initiating ART at low CD4 counts have been clearly demonstrated but whether any excess risk remains even after reaching relatively high/safe CD4 levels remains unclear. We explore whether individuals starting ART with <500 CD4 cells/μL w...

Full description

Bibliographic Details
Main Authors: Nikos Pantazis, Vasilios Paparizos, Vasilios Papastamopoulos, Simeon Metallidis, Anastasia Antoniadou, Georgios Adamis, Mina Psichgiou, Maria Chini, Helen Sambatakou, Georgios Chrysos, Nikolaos V. Sipsas, Charalambos Gogos, Emmanouil Barbunakis, Periklis Panagopoulos, Olga Katsarou, Giota Touloumi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062628/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062628/?tool=EBI

Similar Items